NCT02348723 Uninterrupted Dabigatran Etexilate in Comparison to Uninterrupted Warfarin in Pulmonary Vein Ablation (RE-CIRCUIT) Status COMPLETED Phase PHASE4
NCT02345304 Effect of BI 1181181 on Midazolam, Warfarin, Omeprazole and Digoxin Status WITHDRAWN Phase PHASE1
NCT02342717 Relative Bioavailability of a Single Oral Dose of BI 425809 When Administered Alone or in Combination With Multiple Oral Doses of Itraconazole in Healthy Male Subjects Status COMPLETED Phase PHASE1
NCT02337907 BI 409306 in Patients With Cognitive Impairment Due to Alzheimer's Disease. Status COMPLETED Phase PHASE2
NCT02337283 Safety, Tolerability, and Pharmacokinetics of Multiple Rising Doses of BI 425809 Tablets for 12 Days to Young and Elderly Healthy Male and Female Volunteers and Comparison of Pharmacokinetics of a Single Oral Dose of BI 425809 (Morning Versus Evening) Status COMPLETED Phase PHASE1
NCT02331277 Safety and Pharmacokinetics of Multiple Doses of BI 655064 in Healthy Chinese Male Volunteers Status COMPLETED Phase PHASE1
NCT02308553 Efficacy and Safety of Nintedanib Combined With Paclitaxel Chemotherapy for Patients With BRAF wt Metastatic Melanoma Status COMPLETED Phase PHASE1/PHASE2
NCT02305901 The Effect of Multiple Doses of BI 187004 on the Single-dose Pharmacokinetics of Repaglinide and Bupropion in Healthy Male Volunteers Status COMPLETED Phase PHASE1
NCT02302716 A Study of LY2963016 Compared to LANTUS® in Adult Participants With Type 2 Diabetes Mellitus Status COMPLETED Phase PHASE3
NCT02300311 Efficacy and Safety of Finalgon® Cream Multiple Doses in Acute Low Back Pain Status COMPLETED Phase PHASE3
NCT02300298 Nintedanib Plus Docetaxel in Japanese Patients With Adenocarcinoma Subtype Non-small Cell Lung Cancer After Failure of First Line Chemotherapy Status COMPLETED Phase PHASE1
NCT02296138 Comparing the Efficacy of Tiotropium + Olodaterol (5/5 µg) Fixed Dose Combination (FDC) Over Tiotropium 5µg in Reducing Moderate to Severe Exacerbations in Patients With Severe to Very Severe Chronic Obstructive Pulmonary Disease. Status COMPLETED Phase PHASE3
NCT02281773 A Study to Investigate the Efficacy, Safety and Tolerability of Four Different Doses of BI 409306 Compared to Placebo Given for 12 Weeks in Patients With Schizophrenia on Stable Antipsychotic Treatment. Status COMPLETED Phase PHASE2
NCT02278302 Study to Compare the Effect of a Combination of Dipyridamole With Sustained Release and Acetyl Salicylic Acid (Aggrenox®) on the Performance Relevant to Safety and on the General Condition of Healthy Volunteers Status COMPLETED Phase PHASE1
NCT02276391 Bioequivalence of Telmisartan as Telmisartan 80 mg/HCTZ 12.5 mg Fixed-dose Combination Tablet or as Two Telmisartan 40 mg Tablets in Healthy Male Volunteers Status COMPLETED Phase PHASE1
NCT02276378 Influence of Food on the Bioavailability of Two Doses of Telmisartan/HCTZ Fixed-dose Combination in Japanese Healthy Male Volunteers Status COMPLETED Phase PHASE1
NCT02276365 Bioavailability of BI 10773 and Pioglitazone in Healthy Male Volunteers Status COMPLETED Phase PHASE1